Trial Profile
A Phase IIIb, Randomized, Double-Blind, Parallel Group Study in Bipolar I Patients to Assess the Efficacy and Safety of SPD417 [extended-release carbamazepine; Validus] Administered Once Daily Vs Twice Daily in the Treatment of Manic Symptoms
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2006
Price :
$35
*
At a glance
- Drugs Carbamazepine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Shire
- 03 Oct 2006 New trial record.